ACAD FY 2011 Earnings — ACADIA Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena

ACADACADIA Pharmaceuticals Inc.

$4B

FY 2011 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-95.1% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$23M-1105.6% margin

Net Income

-$23M-1101.4% margin

EPS (Diluted)

$-0.44

Cash Flow

Operating Cash Flow

-$20M

Free Cash Flow

-$20M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$32M

Total Liabilities

$9M

Stockholders' Equity

$23M

Cash & Equivalents

$7M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$42M	-95.1%
Gross Profit	$2M	$42M	-95.1%
Operating Income	-$23M	$15M	-251.4%
Net Income	-$23M	$15M	-250.4%